These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 1322640)

  • 1. Ocular toxoplasmosis in human immunodeficiency virus-infected patients.
    Cochereau-Massin I; LeHoang P; Lautier-Frau M; Zerdoun E; Zazoun L; Robinet M; Marcel P; Girard B; Katlama C; Leport C
    Am J Ophthalmol; 1992 Aug; 114(2):130-5. PubMed ID: 1322640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Presumed toxoplasmic chorioretinitis: comparative study of treatment with pyrimethamine and sulfadiazine or clindamycin].
    Colin J; Harie JC
    J Fr Ophtalmol; 1989; 12(3):161-5. PubMed ID: 2695556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective randomized trial of trimethoprim/sulfamethoxazole versus pyrimethamine and sulfadiazine in the treatment of ocular toxoplasmosis.
    Soheilian M; Sadoughi MM; Ghajarnia M; Dehghan MH; Yazdani S; Behboudi H; Anisian A; Peyman GA
    Ophthalmology; 2005 Nov; 112(11):1876-82. PubMed ID: 16171866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective, randomized trial of pyrimethamine and azithromycin vs pyrimethamine and sulfadiazine for the treatment of ocular toxoplasmosis.
    Bosch-Driessen LH; Verbraak FD; Suttorp-Schulten MS; van Ruyven RL; Klok AM; Hoyng CB; Rothova A
    Am J Ophthalmol; 2002 Jul; 134(1):34-40. PubMed ID: 12095805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Value of clindamycin in the treatment of ocular toxoplasmosis].
    Jeddi A; Azaiez A; Bouguila H; Kaoueche M; Malouche S; Daghfous F; Ayed S
    J Fr Ophtalmol; 1997; 20(6):418-22. PubMed ID: 9296037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quadruple therapy for ocular toxoplasmosis.
    Lam S; Tessler HH
    Can J Ophthalmol; 1993 Apr; 28(2):58-61. PubMed ID: 8508337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of ocular toxoplasmosis with clindamycin and sulfadiazine.
    Tabbara KF; O'Connor GR
    Ophthalmology; 1980 Feb; 87(2):129-34. PubMed ID: 7383542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current treatment of ocular toxoplasmosis in immunocompetent patients: a network meta-analysis.
    Zhang Y; Lin X; Lu F
    Acta Trop; 2018 Sep; 185():52-62. PubMed ID: 29704469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term follow-up of patients with AIDS on maintenance therapy for toxoplasmosis.
    Leport C; Tournerie C; Raguin G; Fernandez-Martin J; Niyongabo T; Vildé JL
    Eur J Clin Microbiol Infect Dis; 1991 Mar; 10(3):191-3. PubMed ID: 2060528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapy for ocular toxoplasmosis.
    Rothova A; Meenken C; Buitenhuis HJ; Brinkman CJ; Baarsma GS; Boen-Tan TN; de Jong PT; Klaassen-Broekema N; Schweitzer CM; Timmerman Z
    Am J Ophthalmol; 1993 Apr; 115(4):517-23. PubMed ID: 8470726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clindamycin in the treatment of toxoplasmosis in AIDS.
    Iannucci AA; Hart LL
    Ann Pharmacother; 1992 May; 26(5):645-7. PubMed ID: 1591424
    [No Abstract]   [Full Text] [Related]  

  • 12. Pyrimethamine-clindamycin vs. pyrimethamine-sulfadiazine as acute and long-term therapy for toxoplasmic encephalitis in patients with AIDS.
    Katlama C; De Wit S; O'Doherty E; Van Glabeke M; Clumeck N
    Clin Infect Dis; 1996 Feb; 22(2):268-75. PubMed ID: 8838183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ocular Toxoplasmosis in a Tertiary Referral Center in Sydney Australia-Clinical Features, Treatment, and Prognosis.
    Yates WB; Chiong F; Zagora S; Post JJ; Wakefield D; McCluskey P
    Asia Pac J Ophthalmol (Phila); 2019; 8(4):280-284. PubMed ID: 31369405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adverse drug reactions to treatments for ocular toxoplasmosis: a retrospective chart review.
    Iaccheri B; Fiore T; Papadaki T; Androudi S; Janjua S; Bhaila I; Stephen Foster C
    Clin Ther; 2008 Nov; 30(11):2069-74. PubMed ID: 19108794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Ocular toxoplasmosis in patients with acquired immunodeficiency syndrome].
    Santín M; Podzamczer D; Bolao F; Prat J; Rufí G; Ariza J; Lillo J
    Med Clin (Barc); 1990 Mar; 94(11):423-5. PubMed ID: 2377016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute acquired toxoplasmosis.
    Reese LT; Shafer DM; Zweifach P
    Ann Ophthalmol; 1981 Apr; 13(4):467-70. PubMed ID: 6972719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clindamycin and sulphonamides in the treatment of ocular toxoplasmosis.
    Guldsten H
    Acta Ophthalmol (Copenh); 1983 Feb; 61(1):51-7. PubMed ID: 6858644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alternative treatment approach to cerebral toxoplasmosis in HIV/AIDS: experience from a resource-poor setting.
    Goswami RP; Goswami RP; Rahman M; Ray Y; Tripathi SK
    Int J STD AIDS; 2015 Oct; 26(12):864-9. PubMed ID: 25411350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fuchs' heterochromic cyclitis: a post-infectious manifestation of ocular toxoplasmosis?
    Jad A; Céline T; Bahram B; Phuc L; Nathalie C
    Int Ophthalmol; 2013 Apr; 33(2):189-94. PubMed ID: 23070707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Toxoplasmosis in AIDS].
    Leport C; Remington JS
    Presse Med; 1992 Jul 4-11; 21(25):1165-71. PubMed ID: 1409466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.